SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 107.14 |
| Enterprise Value ($M) | 54.54 |
| Book Value ($M) | 195.69 |
| Book Value / Share | 2.30 |
| Price / Book | 0.55 |
| NCAV ($M) | 13.08 |
| NCAV / Share | 0.15 |
| Price / NCAV | 8.19 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.52 |
| Return on Assets (ROA) | -0.33 |
| Return on Equity (ROE) | -0.59 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.39 |
| Current Ratio | 10.39 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 206.01 |
| Assets | 388.62 |
| Liabilities | 192.93 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Venrock Healthcare Capital Partners III, L.P. | 6.40 | 58.27 | |
| 13G/A | Casdin Capital, LLC | 3.80 | -38.11 | |
| 13G/A | Fmr Llc | 2.98 | -30.20 | |
| 13G/A | Boxer Capital Management, LLC | 3.70 | ||
| 13G | Bain Capital Life Sciences Opportunities III, LP | 6.60 | ||
| 13G | Boxer Capital, LLC | 5.80 | ||
| 13G/A | Versant Venture Capital VI, L.P. | 19.10 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 97,021 | 592,174 | 16.38 | |
| 59,836 | 525,209 | 11.39 | |
| 86,351 | 645,340 | 13.38 | |
| 46,713 | 339,850 | 13.75 | |
| 35,751 | 268,413 | 13.32 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| INZY – Inozyme Pharma, Inc. | IOBT – IO Biotech, Inc. |
| IONS – Ionis Pharmaceuticals, Inc. | IRWD – Ironwood Pharmaceuticals, Inc. |
| ITCI – Intra-Cellular Therapies, Inc. |
Financial data and stock pages provided by
Fintel.io